Sargramostim 250 mcg/ML Injectable Solution
RxNorm 315199
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 315199 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sargramostim 250 mcg/ML Injectable Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Sargramostim 0.25 mg/ML Injectable Solution
(Atom ID: 1476499)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)
(Atom ID: 10317081)
PSNPrescribable
Prescribable Name (PSN):
Sargramostim 250 mcg/ML Injectable Solution
(Atom ID: 7709456)
SYPrescribable
Synonym (SY):
Sargramostim 250 mcg/ML Injectable Solution
(Atom ID: 3293849)
PTPrescribable
Designated preferred name (PT):
Sargramostim 250 microgram powder for solution for injection vial
(Atom ID: 10320404)
Patient Education
Sargramostim
Sargramostin is used to decrease the chance of infection in people who have acute myelogenous leukemia (AML; a type of cancer of the white blood cells) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Sargramostin is also used in people who are undergoing blood stem cell transplants, in people who are undergoing bone marrow transplants, and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body and then returned to the body following chemotherapy). Sargramostim is also used in people who have not responded after receiving a blood marrow transplant. Sargramostin is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils and certain other blood cells.
[Learn More]
* Please review the disclaimer below.